FACTANKER
Altamira Therapeutics Ltd.: xbrl:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
Value
{"amount": 4346, "currency": "USD"}
Period
2023-01-01 – 2023-12-31
Status
current
Entity
Altamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-25-037199
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER,
https://factanker.com/fact/47253958-7b93-4e5b-91df-8be8a628bd09
History
supersedes
{"unit": "CHF", "value": -3905}
(evidence 0001213900-24-034940)